XML 29 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
3. Segment Information and Concentrations (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Depreciation and Amortization     $ 276,500 $ 319,100
Benchtop Laboratory Equipment [Member]        
Revenues $ 1,410,800 $ 1,279,300 4,334,400 4,125,900
Foreign Sales 611,400 597,300 1,924,400 1,960,700
Income (Loss) from Operations 88,900 2,800 252,900 245,200
Assets 4,170,900 4,358,700 4,170,900 4,358,700
Long-lived Asset Expenditures 4,600 31,500 18,200 39,900
Depreciation and Amortization 73,500 74,800 226,800 222,800
Catalyst Research Instruments [Member]        
Revenues 359,800 364,900 1,629,400 932,300
Foreign Sales 37,100 25,900 52,200 139,200
Income (Loss) from Operations (82,400) 5,500 (197,400) (86,700)
Assets 1,822,200 2,898,400 1,822,200 2,898,400
Long-lived Asset Expenditures 0 3,200 0 3,200
Depreciation and Amortization 1,600 9,000 12,700 22,900
Bioprocessing Systems [Member]        
Revenues 140,300 30,100 190,000 88,700
Foreign Sales 0 0 0 0
Income (Loss) from Operations 76,500 (29,600) 9,100 (92,500)
Assets 485,700 746,200 485,700 746,200
Long-lived Asset Expenditures 7,000 3,700 12,800 9,400
Depreciation and Amortization 12,000 24,500 37,000 73,400
Corporate and Other [Member]        
Revenues 0 0 0 0
Foreign Sales 0 0 0 0
Income (Loss) from Operations 0 (13,800) 0 (35,900)
Assets 719,200 595,000 719,200 595,000
Long-lived Asset Expenditures 0 0 0 0
Depreciation and Amortization 0 0 0 0
Consolidated [Member]        
Revenues 1,910,900 1,674,300 6,153,800 5,146,900
Foreign Sales 648,500 623,200 1,976,600 2,099,900
Income (Loss) from Operations 83,000 (35,100) 64,600 30,100
Assets 7,198,000 8,598,300 7,198,000 8,598,300
Long-lived Asset Expenditures 11,600 38,400 31,000 52,500
Depreciation and Amortization $ 87,100 $ 108,300 $ 276,500 $ 319,100